ReviewImmunogenetics2017
Immune selection during tumor checkpoint inhibition therapy paves way for NK-cell "missing self" recognition.
Karl-Johan Malmberg et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
26 papers cite it
this papercites it